These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 11263172)
81. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: results after six months. Grossman RA; Assawasena V; Chalpati S; Taewtong D Bull World Health Organ; 1977; 55(1):67-78. PubMed ID: 302157 [TBL] [Abstract][Full Text] [Related]
82. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. London RS J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530 [TBL] [Abstract][Full Text] [Related]
83. Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability. Prabhakaran S; Sweet A Contraception; 2012 May; 85(5):453-7. PubMed ID: 22079605 [TBL] [Abstract][Full Text] [Related]
85. Experiences of injectable contraceptive users in an urban setting. Sangi-Haghpeykar H; Poindexter AN; Bateman L; Ditmore JR Obstet Gynecol; 1996 Aug; 88(2):227-33. PubMed ID: 8692507 [TBL] [Abstract][Full Text] [Related]
86. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Clark MK; Sowers M; Levy B; Nichols S Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507 [TBL] [Abstract][Full Text] [Related]
87. DMPA use above the age of 35 in Thai women. Taneepanichskul S; Reinprayoon D; Phaosavadi S Contraception; 2000 Apr; 61(4):281-2. PubMed ID: 10899485 [TBL] [Abstract][Full Text] [Related]
88. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613 [TBL] [Abstract][Full Text] [Related]
90. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal. Burke HM; Mueller MP; Perry B; Packer C; Bufumbo L; Mbengue D; Mall I; Daff BM; Mbonye AK Contraception; 2014 May; 89(5):361-7. PubMed ID: 24631328 [TBL] [Abstract][Full Text] [Related]
91. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States. Upadhyay UD; Zlidar VM; Foster DG Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938 [TBL] [Abstract][Full Text] [Related]
92. Injectable contraception. Roy G Semin Reprod Med; 2010 Mar; 28(2):126-32. PubMed ID: 20352562 [TBL] [Abstract][Full Text] [Related]
93. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis]. Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083 [TBL] [Abstract][Full Text] [Related]
94. Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum. Sönmezer M; Atabekoğlu C; Cengiz B; Dökmeci F; Cengiz SD Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):9-14. PubMed ID: 16036292 [TBL] [Abstract][Full Text] [Related]
95. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood. Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818 [TBL] [Abstract][Full Text] [Related]
96. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria. Adeyemi AS; Adekanle DA Ann Afr Med; 2012; 11(1):27-31. PubMed ID: 22199044 [TBL] [Abstract][Full Text] [Related]
97. A field study of Depo-Provera: its use as a contraceptive method by women in a rural town in West Malaysia from February 1968 to December 1969. Hew Wai Sin ; Peng JY; Dato Ariffin Marzuki Med J Malaysia; 1973 Jun; 27(4):299-305. PubMed ID: 4270790 [TBL] [Abstract][Full Text] [Related]
98. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Westhoff C; Jain JK; Milsom I; Ray A Contraception; 2007 Apr; 75(4):261-7. PubMed ID: 17362703 [TBL] [Abstract][Full Text] [Related]
99. Injectable contraception. Edwards JR Med J Aust; 1981 Jun; 1(12):651-2. PubMed ID: 6454820 [TBL] [Abstract][Full Text] [Related]
100. Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment. Feldblum PJ; Caraway J; Bahamondes L; El-Shafei M; Quan Ha D; Morales E; Wevill S; Condon S Contraception; 2005 Sep; 72(3):187-91. PubMed ID: 16102553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]